中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Effects and molecular mechanism of 5, 8-disubstituted quinazolines-LJK-11 in HER2 overexpressing cells

文献类型:期刊论文

作者QIN Lili2; JIN Yi1; LONG Yaqiu1; YU Qiang1; HE Jianyong2
刊名Journal of Shenyang Pharmaceutical University
出版日期2007
卷号24期号:1页码:53
关键词LJK-11 HER2 LJK-11 tyrosine kinase inhibitor tumor HER2 cell death
ISSN号1006-2858
其他题名5,8-二代喹唑啉类化合物LJK-11对HER2高表达肿瘤细胞的作用和分子机制初探
文献子类Article
英文摘要Objective To investigate the effects and molecular mechanism of LJK-11 on tumor cell. Methods The growth inhibition effects of LJK-11 on different tumor cell were measured by MTT assay. The effects on the expression and phosphorylation of HER2 were analyzed by western blot analysis. Results LJK-11 inhibited tumor cell growth in concentration-dependent manner. LJK-11 inhibited the phosphorylation of HER2.Conclusions LJK-11 may be developed as a novel kinase inhibitor. The inhibitory mechanism of LJK-11 provides a theoretical guidance for the development of novel anti-cancer agents.
WOS研究方向Pharmacology & Pharmacy (provided by Clarivate Analytics)
语种中文
CSCD记录号CSCD:2734119
源URL[http://119.78.100.183/handle/2S10ELR8/268146]  
专题药物安全性评价中心
药理学第一研究室
作者单位1.Shanghai Institute of Medicine Research , Chinese Academic of Science, Shanghai 201203, China.
2.School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.;
推荐引用方式
GB/T 7714
QIN Lili,JIN Yi,LONG Yaqiu,et al. Effects and molecular mechanism of 5, 8-disubstituted quinazolines-LJK-11 in HER2 overexpressing cells[J]. Journal of Shenyang Pharmaceutical University,2007,24(1):53.
APA QIN Lili,JIN Yi,LONG Yaqiu,YU Qiang,&HE Jianyong.(2007).Effects and molecular mechanism of 5, 8-disubstituted quinazolines-LJK-11 in HER2 overexpressing cells.Journal of Shenyang Pharmaceutical University,24(1),53.
MLA QIN Lili,et al."Effects and molecular mechanism of 5, 8-disubstituted quinazolines-LJK-11 in HER2 overexpressing cells".Journal of Shenyang Pharmaceutical University 24.1(2007):53.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。